Robert LaCaze, incoming CEO of Mnemo Therapeutics
Bayer oncology vet Robert LaCaze has his eyes on next steps — landing his first gig as CEO of Sadelain co-founded biotech
Three weeks after Bayer put out word that Robert LaCaze, its head of their oncology strategic business unit, was jumping ship, we now know where …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
